 | • レポートコード：MRC2Q12-16825 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、プラスミドDNA生産のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 プラスミドDNA生産のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 プラスミドDNA生産の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 プラスミドDNA生産のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのプラスミドDNA生産の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のプラスミドDNA生産の売上および2028年までの予測に焦点を当てています。 プラスミドDNA生産のグローバル主要企業には、Charles River、Lonza、Aldevron、Thermo Fisher Scientific、Catalent、The Discovery Labs、BIOCENTRIQ、FUJIFILM Diosynth Biotechnologies、Exothera、WuXi AppTec、Pharmaron、OBiO、Cell Therapies、AGC Biologics、Cytiva、Helixmith、ThermoGenesis、Anemocyte、CBM、Bio Elpida、Genezen、CCRM、RoslinCT、GenScript ProBio、Oxford BioMedica、Porton Pharma Solutionsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 プラスミドDNA生産市場は、タイプとアプリケーションによって区分されます。世界のプラスミドDNA生産市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 前臨床プラスミド、臨床プラスミド、商用プラスミド 【アプリケーション別セグメント】 商業用、学術研究、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - プラスミドDNA生産製品概要 - タイプ別市場（前臨床プラスミド、臨床プラスミド、商用プラスミド） - アプリケーション別市場（商業用、学術研究、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のプラスミドDNA生産販売量予測2017-2028 - 世界のプラスミドDNA生産売上予測2017-2028 - プラスミドDNA生産の地域別販売量 - プラスミドDNA生産の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別プラスミドDNA生産販売量 - 主要メーカー別プラスミドDNA生産売上 - 主要メーカー別プラスミドDNA生産価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（前臨床プラスミド、臨床プラスミド、商用プラスミド） - プラスミドDNA生産のタイプ別販売量 - プラスミドDNA生産のタイプ別売上 - プラスミドDNA生産のタイプ別価格 ・アプリケーション別市場規模（商業用、学術研究、その他） - プラスミドDNA生産のアプリケーション別販売量 - プラスミドDNA生産のアプリケーション別売上 - プラスミドDNA生産のアプリケーション別価格 ・北米市場 - 北米のプラスミドDNA生産市場規模（タイプ別、アプリケーション別） - 主要国別のプラスミドDNA生産市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのプラスミドDNA生産市場規模（タイプ別、アプリケーション別） - 主要国別のプラスミドDNA生産市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のプラスミドDNA生産市場規模（タイプ別、アプリケーション別） - 主要国別のプラスミドDNA生産市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のプラスミドDNA生産市場規模（タイプ別、アプリケーション別） - 主要国別のプラスミドDNA生産市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのプラスミドDNA生産市場規模（タイプ別、アプリケーション別） - 主要国別のプラスミドDNA生産市場規模（トルコ、サウジアラビア） ・企業情報 Charles River、Lonza、Aldevron、Thermo Fisher Scientific、Catalent、The Discovery Labs、BIOCENTRIQ、FUJIFILM Diosynth Biotechnologies、Exothera、WuXi AppTec、Pharmaron、OBiO、Cell Therapies、AGC Biologics、Cytiva、Helixmith、ThermoGenesis、Anemocyte、CBM、Bio Elpida、Genezen、CCRM、RoslinCT、GenScript ProBio、Oxford BioMedica、Porton Pharma Solutions ・産業チェーン及び販売チャネル分析 - プラスミドDNA生産の産業チェーン分析 - プラスミドDNA生産の原材料 - プラスミドDNA生産の生産プロセス - プラスミドDNA生産の販売及びマーケティング - プラスミドDNA生産の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - プラスミドDNA生産の産業動向 - プラスミドDNA生産のマーケットドライバー - プラスミドDNA生産の課題 - プラスミドDNA生産の阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Plasmid DNA Production estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Plasmid DNA Production is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Plasmid DNA Production is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Plasmid DNA Production is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key companies of Plasmid DNA Production include Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Plasmid DNA Production companies, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Plasmid DNA Production market. Further, it explains the major drivers and regional dynamics of the global Plasmid DNA Production market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Charles River
Lonza
Aldevron
Thermo Fisher Scientific
Catalent
The Discovery Labs
BIOCENTRIQ
FUJIFILM Diosynth Biotechnologies
Exothera
WuXi AppTec
Pharmaron
OBiO
Cell Therapies
AGC Biologics
Cytiva
Helixmith
ThermoGenesis
Anemocyte
CBM
Bio Elpida
Genezen
CCRM
RoslinCT
GenScript ProBio
Oxford BioMedica
Porton Pharma Solutions
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.
Plasmid DNA Production Segment by Type
Preclinical Plasmid
Clinical Plasmid
Commercial Plasmid
Plasmid DNA Production Segment by Application
Commercial
Academic Research
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Plasmid DNA Production market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Plasmid DNA Production market size. Analyses of the global market trends, with historic market revenue data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Plasmid DNA Production, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Plasmid DNA Production, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Plasmid DNA Production revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Plasmid DNA Production market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Plasmid DNA Production revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Charles River, Lonza, Aldevron, Thermo Fisher Scientific, Catalent, The Discovery Labs, BIOCENTRIQ, FUJIFILM Diosynth Biotechnologies and Exothera, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Plasmid DNA Production in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Plasmid DNA Production companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country/region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Plasmid DNA Production revenue, gross margin, and recent development, etc.
Chapter 12: Analyst’s Viewpoints/Conclusions
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Plasmid DNA Production Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Preclinical Plasmid
1.2.3 Clinical Plasmid
1.2.4 Commercial Plasmid
1.3 Market by Application
1.3.1 Global Plasmid DNA Production Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Commercial
1.3.3 Academic Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Plasmid DNA Production Market Perspective (2017-2028)
2.2 Plasmid DNA Production Growth Trends by Region
2.2.1 Plasmid DNA Production Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Plasmid DNA Production Historic Market Size by Region (2017-2022)
2.2.3 Plasmid DNA Production Forecasted Market Size by Region (2023-2028)
2.3 Plasmid DNA Production Market Dynamics
2.3.1 Plasmid DNA Production Industry Trends
2.3.2 Plasmid DNA Production Market Drivers
2.3.3 Plasmid DNA Production Market Challenges
2.3.4 Plasmid DNA Production Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Plasmid DNA Production Players by Revenue
3.1.1 Global Top Plasmid DNA Production Players by Revenue (2017-2022)
3.1.2 Global Plasmid DNA Production Revenue Market Share by Players (2017-2022)
3.2 Global Plasmid DNA Production Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Plasmid DNA Production Revenue
3.4 Global Plasmid DNA Production Market Concentration Ratio
3.4.1 Global Plasmid DNA Production Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Plasmid DNA Production Revenue in 2021
3.5 Plasmid DNA Production Key Players Head office and Area Served
3.6 Key Players Plasmid DNA Production Product Solution and Service
3.7 Date of Enter into Plasmid DNA Production Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Plasmid DNA Production Breakdown Data by Type
4.1 Global Plasmid DNA Production Historic Market Size by Type (2017-2022)
4.2 Global Plasmid DNA Production Forecasted Market Size by Type (2023-2028)
5 Plasmid DNA Production Breakdown Data by Application
5.1 Global Plasmid DNA Production Historic Market Size by Application (2017-2022)
5.2 Global Plasmid DNA Production Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Plasmid DNA Production Market Size (2017-2028)
6.2 North America Plasmid DNA Production Market Size by Type
6.2.1 North America Plasmid DNA Production Market Size by Type (2017-2022)
6.2.2 North America Plasmid DNA Production Market Size by Type (2023-2028)
6.2.3 North America Plasmid DNA Production Market Share by Type (2017-2028)
6.3 North America Plasmid DNA Production Market Size by Application
6.3.1 North America Plasmid DNA Production Market Size by Application (2017-2022)
6.3.2 North America Plasmid DNA Production Market Size by Application (2023-2028)
6.3.3 North America Plasmid DNA Production Market Share by Application (2017-2028)
6.4 North America Plasmid DNA Production Market Size by Country
6.4.1 North America Plasmid DNA Production Market Size by Country (2017-2022)
6.4.2 North America Plasmid DNA Production Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Plasmid DNA Production Market Size (2017-2028)
7.2 Europe Plasmid DNA Production Market Size by Type
7.2.1 Europe Plasmid DNA Production Market Size by Type (2017-2022)
7.2.2 Europe Plasmid DNA Production Market Size by Type (2023-2028)
7.2.3 Europe Plasmid DNA Production Market Share by Type (2017-2028)
7.3 Europe Plasmid DNA Production Market Size by Application
7.3.1 Europe Plasmid DNA Production Market Size by Application (2017-2022)
7.3.2 Europe Plasmid DNA Production Market Size by Application (2023-2028)
7.3.3 Europe Plasmid DNA Production Market Share by Application (2017-2028)
7.4 Europe Plasmid DNA Production Market Size by Country
7.4.1 Europe Plasmid DNA Production Market Size by Country (2017-2022)
7.4.2 Europe Plasmid DNA Production Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Plasmid DNA Production Market Size (2017-2028)
8.2 Asia-Pacific Plasmid DNA Production Market Size by Type
8.2.1 Asia-Pacific Plasmid DNA Production Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Plasmid DNA Production Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Plasmid DNA Production Market Share by Type (2017-2028)
8.3 Asia-Pacific Plasmid DNA Production Market Size by Application
8.3.1 Asia-Pacific Plasmid DNA Production Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Plasmid DNA Production Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Plasmid DNA Production Market Share by Application (2017-2028)
8.4 Asia-Pacific Plasmid DNA Production Market Size by Region
8.4.1 Asia-Pacific Plasmid DNA Production Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Plasmid DNA Production Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Plasmid DNA Production Market Size (2017-2028)
9.2 Latin America Plasmid DNA Production Market Size by Type
9.2.1 Latin America Plasmid DNA Production Market Size by Type (2017-2022)
9.2.2 Latin America Plasmid DNA Production Market Size by Type (2023-2028)
9.2.3 Latin America Plasmid DNA Production Market Share by Type (2017-2028)
9.3 Latin America Plasmid DNA Production Market Size by Application
9.3.1 Latin America Plasmid DNA Production Market Size by Application (2017-2022)
9.3.2 Latin America Plasmid DNA Production Market Size by Application (2023-2028)
9.3.3 Latin America Plasmid DNA Production Market Share by Application (2017-2028)
9.4 Latin America Plasmid DNA Production Market Size by Country
9.4.1 Latin America Plasmid DNA Production Market Size by Country (2017-2022)
9.4.2 Latin America Plasmid DNA Production Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Plasmid DNA Production Market Size (2017-2028)
10.2 Middle East & Africa Plasmid DNA Production Market Size by Type
10.2.1 Middle East & Africa Plasmid DNA Production Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Plasmid DNA Production Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Plasmid DNA Production Market Share by Type (2017-2028)
10.3 Middle East & Africa Plasmid DNA Production Market Size by Application
10.3.1 Middle East & Africa Plasmid DNA Production Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Plasmid DNA Production Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Plasmid DNA Production Market Share by Application (2017-2028)
10.4 Middle East & Africa Plasmid DNA Production Market Size by Country
10.4.1 Middle East & Africa Plasmid DNA Production Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Plasmid DNA Production Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Plasmid DNA Production Introduction
11.1.4 Charles River Revenue in Plasmid DNA Production Business (2017-2022)
11.1.5 Charles River Recent Developments
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Plasmid DNA Production Introduction
11.2.4 Lonza Revenue in Plasmid DNA Production Business (2017-2022)
11.2.5 Lonza Recent Developments
11.3 Aldevron
11.3.1 Aldevron Company Details
11.3.2 Aldevron Business Overview
11.3.3 Aldevron Plasmid DNA Production Introduction
11.3.4 Aldevron Revenue in Plasmid DNA Production Business (2017-2022)
11.3.5 Aldevron Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Plasmid DNA Production Introduction
11.4.4 Thermo Fisher Scientific Revenue in Plasmid DNA Production Business (2017-2022)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent Plasmid DNA Production Introduction
11.5.4 Catalent Revenue in Plasmid DNA Production Business (2017-2022)
11.5.5 Catalent Recent Developments
11.6 The Discovery Labs
11.6.1 The Discovery Labs Company Details
11.6.2 The Discovery Labs Business Overview
11.6.3 The Discovery Labs Plasmid DNA Production Introduction
11.6.4 The Discovery Labs Revenue in Plasmid DNA Production Business (2017-2022)
11.6.5 The Discovery Labs Recent Developments
11.7 BIOCENTRIQ
11.7.1 BIOCENTRIQ Company Details
11.7.2 BIOCENTRIQ Business Overview
11.7.3 BIOCENTRIQ Plasmid DNA Production Introduction
11.7.4 BIOCENTRIQ Revenue in Plasmid DNA Production Business (2017-2022)
11.7.5 BIOCENTRIQ Recent Developments
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Plasmid DNA Production Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Plasmid DNA Production Business (2017-2022)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments
11.9 Exothera
11.9.1 Exothera Company Details
11.9.2 Exothera Business Overview
11.9.3 Exothera Plasmid DNA Production Introduction
11.9.4 Exothera Revenue in Plasmid DNA Production Business (2017-2022)
11.9.5 Exothera Recent Developments
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Details
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec Plasmid DNA Production Introduction
11.10.4 WuXi AppTec Revenue in Plasmid DNA Production Business (2017-2022)
11.10.5 WuXi AppTec Recent Developments
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron Plasmid DNA Production Introduction
11.11.4 Pharmaron Revenue in Plasmid DNA Production Business (2017-2022)
11.11.5 Pharmaron Recent Developments
11.12 OBiO
11.12.1 OBiO Company Details
11.12.2 OBiO Business Overview
11.12.3 OBiO Plasmid DNA Production Introduction
11.12.4 OBiO Revenue in Plasmid DNA Production Business (2017-2022)
11.12.5 OBiO Recent Developments
11.13 Cell Therapies
11.13.1 Cell Therapies Company Details
11.13.2 Cell Therapies Business Overview
11.13.3 Cell Therapies Plasmid DNA Production Introduction
11.13.4 Cell Therapies Revenue in Plasmid DNA Production Business (2017-2022)
11.13.5 Cell Therapies Recent Developments
11.14 AGC Biologics
11.14.1 AGC Biologics Company Details
11.14.2 AGC Biologics Business Overview
11.14.3 AGC Biologics Plasmid DNA Production Introduction
11.14.4 AGC Biologics Revenue in Plasmid DNA Production Business (2017-2022)
11.14.5 AGC Biologics Recent Developments
11.15 Cytiva
11.15.1 Cytiva Company Details
11.15.2 Cytiva Business Overview
11.15.3 Cytiva Plasmid DNA Production Introduction
11.15.4 Cytiva Revenue in Plasmid DNA Production Business (2017-2022)
11.15.5 Cytiva Recent Developments
11.16 Helixmith
11.16.1 Helixmith Company Details
11.16.2 Helixmith Business Overview
11.16.3 Helixmith Plasmid DNA Production Introduction
11.16.4 Helixmith Revenue in Plasmid DNA Production Business (2017-2022)
11.16.5 Helixmith Recent Developments
11.17 ThermoGenesis
11.17.1 ThermoGenesis Company Details
11.17.2 ThermoGenesis Business Overview
11.17.3 ThermoGenesis Plasmid DNA Production Introduction
11.17.4 ThermoGenesis Revenue in Plasmid DNA Production Business (2017-2022)
11.17.5 ThermoGenesis Recent Developments
11.18 Anemocyte
11.18.1 Anemocyte Company Details
11.18.2 Anemocyte Business Overview
11.18.3 Anemocyte Plasmid DNA Production Introduction
11.18.4 Anemocyte Revenue in Plasmid DNA Production Business (2017-2022)
11.18.5 Anemocyte Recent Developments
11.19 CBM
11.19.1 CBM Company Details
11.19.2 CBM Business Overview
11.19.3 CBM Plasmid DNA Production Introduction
11.19.4 CBM Revenue in Plasmid DNA Production Business (2017-2022)
11.19.5 CBM Recent Developments
11.20 Bio Elpida
11.20.1 Bio Elpida Company Details
11.20.2 Bio Elpida Business Overview
11.20.3 Bio Elpida Plasmid DNA Production Introduction
11.20.4 Bio Elpida Revenue in Plasmid DNA Production Business (2017-2022)
11.20.5 Bio Elpida Recent Developments
11.21 Genezen
11.21.1 Genezen Company Details
11.21.2 Genezen Business Overview
11.21.3 Genezen Plasmid DNA Production Introduction
11.21.4 Genezen Revenue in Plasmid DNA Production Business (2017-2022)
11.21.5 Genezen Recent Developments
11.22 CCRM
11.22.1 CCRM Company Details
11.22.2 CCRM Business Overview
11.22.3 CCRM Plasmid DNA Production Introduction
11.22.4 CCRM Revenue in Plasmid DNA Production Business (2017-2022)
11.22.5 CCRM Recent Developments
11.23 RoslinCT
11.23.1 RoslinCT Company Details
11.23.2 RoslinCT Business Overview
11.23.3 RoslinCT Plasmid DNA Production Introduction
11.23.4 RoslinCT Revenue in Plasmid DNA Production Business (2017-2022)
11.23.5 RoslinCT Recent Developments
11.24 GenScript ProBio
11.24.1 GenScript ProBio Company Details
11.24.2 GenScript ProBio Business Overview
11.24.3 GenScript ProBio Plasmid DNA Production Introduction
11.24.4 GenScript ProBio Revenue in Plasmid DNA Production Business (2017-2022)
11.24.5 GenScript ProBio Recent Developments
11.25 Oxford BioMedica
11.25.1 Oxford BioMedica Company Details
11.25.2 Oxford BioMedica Business Overview
11.25.3 Oxford BioMedica Plasmid DNA Production Introduction
11.25.4 Oxford BioMedica Revenue in Plasmid DNA Production Business (2017-2022)
11.25.5 Oxford BioMedica Recent Developments
11.26 Porton Pharma Solutions
11.26.1 Porton Pharma Solutions Company Details
11.26.2 Porton Pharma Solutions Business Overview
11.26.3 Porton Pharma Solutions Plasmid DNA Production Introduction
11.26.4 Porton Pharma Solutions Revenue in Plasmid DNA Production Business (2017-2022)
11.26.5 Porton Pharma Solutions Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer